If you’re a researcher new to bringing a technology you discovered to market, the tech transfer process may seem daunting.

Axcynsis Therapeutics Pte Ltd ("Axcynsis"), a privately held biopharmaceutical company specialized in delivering Antibody Drug Conjugates (ADCs) with breakthrough potential, proudly announces the ...

The global Competent Cells Market is on a rapid growth trajectory, valued at US$ 2.1 billion in 2022. The market is projected to expand at an impressive CAGR of 11.1% during the forecast period, ...

They also note that the technology requires deep sequencing (at least 80x coverage) of the DNA, which could limit its accessibility due to cost and complexity. Future studies will explore whether ...

His influence extended beyond research, having served on the NIH Recombinant DNA ... and Technology (AIST) and a member of prestigious academies worldwide, including the U.S. National Academy of ...

Microbix offering recombinant Antigens will increase the extent to which it can grow sales of this important segment of its business. Microbix has therefore decided to fund the augmentation of its ...

The National Eligibility cum Entrance Test (NEET) is a competitive medical entrance examination in India for admission to undergraduate medical courses such as MBBS and BDS. Biology is often regarded ...

Conclusion: KAE improve ALI by inhibiting the release of cytosolic DNA and suppressing cGAS-STING pathway activation, thereby protecting cells from PANoptosis. Our findings provide valuable insights ...

Department of Chemistry, Saint Louis University, Saint Louis, Missouri 63103, United States Institute for Drug and Biotherapeutic Innovation, Saint Louis University, Saint Louis, Missouri 63103, ...